Posted inWire
QIAGEN to acquire Parse Biosciences for $225 million in single-cell push
AMSTERDAM - Life sciences company QIAGEN NV said on Monday it has agreed to acquire Parse Biosciences, a provider of single-cell sequencing solutions, for an upfront $225 million in cash,…